A synthetic bispecific antibody capable of neutralizing SARS-CoV-2 Delta and Omicron
T. Z. Yuan, C. Lucas, V. S. Monteiro, A. Iwasaki, M. L. Yang, H. F. Nepita, A. G. Lujan Hernandez, J. M. Taft, L. Frei, S. T. Reddy, C. Weber, K. P. Malobisky, R. Mesquita, A. Sato
This paper describes a synthetic bispecific antibody that neutralizes SARS-CoV-2 Delta and Omicron variants with picomolar affinity.
bioRxiv · Jan 4, 2022 · PreprintImmunology